Documents
Application Sponsors
ANDA 213796 | EDENBRIDGE PHARMS | |
Marketing Status
Application Products
001 | CAPSULE;ORAL | EQ 150MG BASE | 0 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-04-19 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
EDENBRIDGE PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 213796
[companyName] => EDENBRIDGE PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"DOXEPIN HYDROCHLORIDE","activeIngredients":"DOXEPIN HYDROCHLORIDE","strength":"EQ 150MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"04\/19\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-04-19
)
)